Wells Fargo’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6K | Buy |
|
|||||
|
2025
Q1 | $25K | Sell |
|
|||||
|
2024
Q4 | $74.4K | Buy |
|
|||||
|
2024
Q3 | $113K | Buy |
|
|||||
|
2024
Q2 | $171K | Buy |
|
|||||
|
2024
Q1 | $347K | Buy |
|
|||||
|
2023
Q4 | $230K | Buy |
|
|||||
|
2023
Q3 | $190K | Sell |
|
|||||
|
2023
Q2 | $515K | Buy |
|
|||||
|
2023
Q1 | $888K | Buy |
|
|||||
|
2022
Q4 | $377K | Sell |
|
|||||
|
2022
Q3 | $221K | Buy |
|
|||||
|
2022
Q2 | $222K | Buy |
|
|||||
|
2022
Q1 | $288K | Sell |
|
|||||
|
2021
Q4 | $400K | Buy |
|
|||||
|
2021
Q3 | $298K | Buy |
|
|||||
|
2021
Q2 | $275K | Sell |
|
|||||
|
2021
Q1 | $542K | Sell |
|
|||||
|
2020
Q4 | $1.43M | Buy |
|
|||||
|
2020
Q3 | $526K | Sell |
|
|||||
|
2020
Q2 | $813K | Buy |
|
|||||
|
2020
Q1 | $184K | Sell |
|
|||||
|
2019
Q4 | $244K | Buy |
|
|||||
|
2019
Q3 | $78K | Buy |
|
|||||
|
2019
Q2 | $3K | Sell |
|
|||||
|
2019
Q1 | $4K | Buy |
|
|||||
|
2018
Q4 | $1K | Hold |
|
|||||
|
2018
Q3 | $2K | Hold |
|
|||||
|
2018
Q2 | $3K | Buy |
|